
Control of Haemophilia: Haemophilia Care in Developing Countries Report of a joint WHO/WFH Meeting
This joint WFH/WHO report outlines the possibilities and priorities for hemophilia care delivery in the developing world
Year: 2020
Language: English
Author(s): World Federation of Hemophilia
Format: Video
In this session from the WFH 2020 Virtual Summit, Glenn Pierce, Alok Srivastava, Steven Pipe, Manuel Carcao, Margaret Ragni and Johnny Mahlangu present and discuss updates to the WFH Guidelines for the Management of Hemophilia.
Discussion topics include hemostatic agents, prophylaxis, inhibitors, and treatment of specific hemorrhages.
Click below to access more on-demand Virtual Summit recordings.
The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.
The WFH does not promote any particular pharmaceutical product and any mention of any commercial brand in this presentation is strictly for educational purposes.

This joint WFH/WHO report outlines the possibilities and priorities for hemophilia care delivery in the developing world

Jointly produced by the WFH and WHO, this publication provides guidance on the development of a successful national care program

This joint WFH/WHO report reviews those issues surrounding management of hemophilia and its complications.

Summarizes discussions and recommendations for the prevention and control of hemophilia made by participants at a joint WHO/WFH Meeting.